Oaktree Acquisition Corp. III Life Sciences (OACC) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The company is headquartered in Los Angeles, CA, United States. The current CEO is Mathew Pendo.
OACC has IPO date of 2024-12-16, 3 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $263.04M.
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
